“…Articles belonging to the medicinal/pharmaceutical research domain were primarily focused on new plant-origin ingredients to be used in pharmacy [105], medicine [106][107][108][109][110][111] and cosmetics [112].…”
“…Genetically modified plants and transgenic seeds could be used to develop and produce new pharmaceutical vaccines or products [109]. For example, carrot (Daucus carota L.) was used to produce biopharmaceuticals (vaccines and enzymes) for human use [27].…”
Plants maintain the ecological equilibrium of the earth and stabilize the ecosystem. Today, traditional commodities and new value-added markets can be served simultaneously. There is significant biosource and bioprocess innovation for biobased industrial products. Furthermore, plant-based innovation is associated with the transition to sustainability. This study performed a bibliometric and in-depth content analysis to review plant-based innovations in the research field between 1995 and 2022. A set of 313 articles was identified from the Scopus and Web of Science databases. Different analytical scientometric tools (topic mapping and overlay visualization networks) were used to analyze 124 articles; the most influential countries, institutions, authors, journals and articles were identified. Through in-depth studies, based on the grounded theory approach, five leading research areas related to plant-based innovation were determined: (1) agricultural/environmental innovation, (2) plant-based food or feed innovation, (3) innovation within the medical/pharmaceutical research area, (4) technology-related innovation and (5) economic/business aspects of plant-based innovations. Future research directions include exploring less examined and new topics, such as the sustainability implications of incorporating various plant-based foods and Industry 4.0 in plant-based innovation, and linking and developing findings from different research areas.
“…Articles belonging to the medicinal/pharmaceutical research domain were primarily focused on new plant-origin ingredients to be used in pharmacy [105], medicine [106][107][108][109][110][111] and cosmetics [112].…”
“…Genetically modified plants and transgenic seeds could be used to develop and produce new pharmaceutical vaccines or products [109]. For example, carrot (Daucus carota L.) was used to produce biopharmaceuticals (vaccines and enzymes) for human use [27].…”
Plants maintain the ecological equilibrium of the earth and stabilize the ecosystem. Today, traditional commodities and new value-added markets can be served simultaneously. There is significant biosource and bioprocess innovation for biobased industrial products. Furthermore, plant-based innovation is associated with the transition to sustainability. This study performed a bibliometric and in-depth content analysis to review plant-based innovations in the research field between 1995 and 2022. A set of 313 articles was identified from the Scopus and Web of Science databases. Different analytical scientometric tools (topic mapping and overlay visualization networks) were used to analyze 124 articles; the most influential countries, institutions, authors, journals and articles were identified. Through in-depth studies, based on the grounded theory approach, five leading research areas related to plant-based innovation were determined: (1) agricultural/environmental innovation, (2) plant-based food or feed innovation, (3) innovation within the medical/pharmaceutical research area, (4) technology-related innovation and (5) economic/business aspects of plant-based innovations. Future research directions include exploring less examined and new topics, such as the sustainability implications of incorporating various plant-based foods and Industry 4.0 in plant-based innovation, and linking and developing findings from different research areas.
“…Na época, a UE declarou que não via motivos para mudar seu atual quadro regulatório, ao mesmo tempo em que aumentava a pressão sobre os Estados membros recalcitrantes para que deixassem de usar medidas nacionais de salvaguarda. Assim, estava criada a controvérsia transatlântica, onde o veredicto da OMC negou a relevância da "abordagem de precaução" da UE à biotecnologia, que a UE havia A técnica do DNA recombinante hoje é considerada como ciência primordial, sendo permitido produzir, modificar produtos e processos ou criar serviços de alto impacto para diversos segmentos industriais 3 , sendo isso aceito culturalmente pelo governo brasileiro 4 .…”
“…A técnica do DNA recombinante hoje é considerada como ciência primordial, reconhecida assim, oficialmente em 2000, tendo proporcionado a possibilidade da transformação genômica dos seres vivos e de outras espécies. O resultado é visto e administrado pela biotecnologia no objetivo de produzir ou de modificar produtos e processos visando um uso específico, como também para criar novos serviços de alto impacto para diversos segmentos 1 .…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.